ESR1 and breast carcinoma: We sought to determine whether endocrine therapy administered concurrently with radiotherapy had a radiosensitizing or radioprotective effect and evaluated whether SERMs, SERDs, estrogen-depleted, or estradiol-stimulated conditions had differential effects on radiosensitization using multiple ER + breast cancer cell lines and an in vivo xenograft model.